Safety and efficacy of combined treatment with tumor-infiltrating lymphocytes and oncolytic adenovirus TILT-123 in metastatic melanoma
2025 · Cell Reports Medicine · 9 citations
https://doi.org/10.1016/j.xcrm.2025.102016
B
Benedetta Albieri
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
49
Papers
109
Citations
5
h-index
5
i10-index
Benedetta Albieri is an academic researcher. The author has contributed to research in topics: Immunotherapy and Immune Responses & CAR-T cell therapy research & Melanoma and MAPK Pathways. The author has an h-index of 5, co-authored 42 publications.
ORCID: 0009-0008-3202-5452Papers by this author
worksDurable complete response after combined treatment with tumor-infiltrating lymphocytes and oncolytic adenovirus (TILT-123) in a patient with metastatic mucosal melanoma
2024 · Immuno-Oncology Technology · 4 citations
https://doi.org/10.1016/j.iotech.2024.100726
Supplementary Material 1 from Uncoupling CD4<sup>+</sup> TIL-mediated tumor killing from JAK-signaling in melanoma
2024 · 0 citations
https://doi.org/10.1158/1078-0432.27031372.v1
Supplementary Data 1 from Uncoupling CD4<sup>+</sup> TIL-mediated tumor killing from JAK-signaling in melanoma
2024 · 0 citations
https://doi.org/10.1158/1078-0432.27031381.v1
Supplementary Data 3 from Uncoupling CD4<sup>+</sup> TIL-mediated tumor killing from JAK-signaling in melanoma
2024 · 0 citations
https://doi.org/10.1158/1078-0432.27031375
Supplementary Data 1 from Uncoupling CD4<sup>+</sup> TIL-mediated tumor killing from JAK-signaling in melanoma
2024 · 0 citations
https://doi.org/10.1158/1078-0432.27031381
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat